Delivery Order SPE2DB20D1100-SPE2DB24FB5H9
- Not listed
- This federal contract award, with a value of $1,083.54, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Spiriva Respimat 1.25 MCG inhalation solution, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract is a firm fixed-price delivery order with a completion date of September 19, 2024. AmerisourceBergen, through its...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.32 firm fixed-price contract is for the supply of Spiriva Respimat 2.5 mcg inhalers, a medication used to treat chronic obstructive pulmonary disease (COPD). The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award, valued at $3,140.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Spiriva Respimat 2.5 MCG inhalation medication, which is a prescription drug used to treat chronic obstructive pulmonary disease (COPD). The contract is a firm-fixed-price delivery order with an ultimate completion date of August 16, 2022. This award is...
- This federal contract award, valued at $3,059.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, a treatment for chronic obstructive pulmonary disease (COPD). The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2023. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.17 firm fixed-price delivery order is for the supply of Spiriva Respimat 2.5 mcg Inhalation, a prescription medication used to treat chronic obstructive pulmonary disease (COPD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA...
- This federal contract award, valued at $3,397.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Spiriva Respimat 1.25 mcg inhalation drug, a pharmaceutical product used to treat respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through September 27, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award, valued at $1,295.08, is a firm fixed price delivery order for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Spiriva Respimat 2.5 mcg inhalers. The $3,578.37 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that supports U.S. military healthcare. The contract has an ultimate completion date of September 14, 2022 and was awarded on September 13, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a...
- This is a $1,653.06 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a performance period through May 2, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,477.15 contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of December 11, 2023 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB5H9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.10 contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA and the parent company, Cencora, Inc. (doing business as AmerisourceBergen). The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation solution, a medication used to treat chronic obstructive pulmonary disease (COPD). It is a firm-fixed-price contract with a completion date of May 1, 2024. The contract was awarded on April 30, 2024 and did not have any set-aside designation, indicating open competition. This contract award is part of AmerisourceBergen's broader role as a critical supplier of pharmaceutical products and medical supplies to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 4/30/24 |